EMA/800704/2012 Page 1/11

21 June 2016 EMA/800704/2012 Stakeholders and Communication Division

Healthcare professionals’ organisation funding sources

NAME OF ORGANISATION: EUROPEAN ASSOCIATION OF HOSPITAL PHARMACISTS

YEAR: 2015-2016

Industry[1] related income

Name of company/ funder Percentage of

overall budget

EXHIBITION Added Pharma - NL 0,26%

B.Braun Melsungen AG - DE 0,53%

Baxter - CH 0,66%

CareFusion Switzerland 317 Sárl Accounts Payable - CH 0,26%

Computer Engineering - FR 0,26%

HD Medi B.V. - NL 0,53%

Fresenius Kabi Deutschland Gmbh - DE 0,79%

Grifols International S.A. - ES 0,33%

Hameln Pharma plus GmbH - DE 0,26%

ICU Medical Europe SRL - IT 0,53%

Medac GmbH - DE 0,53%

Medical Packaging - US 0,26%

Omnicell - US 1,06%

ITAB Sintek International AB - SE 0,20%

Axon Machine Vision GmbH & Co. KG - DE 0,26%

Sinteco Spa - IT 0,26%

MedicoPack A/S - DK 0,26%

Action Travel - BE 0,02%

Swisslog Italia S.p.A. - IT 0,60%

Medi-Dose - US 0,26%

EMA/800704/2012 Page 2/11

Robotik Technology - FR 0,01%

JCE BIOTECHNOLOGY - FR 0,26%

BIQ, Lda. - PT 0,15%

Biotest AG - DE 0,35%

Allied Pharmacy Products - US 0,10%

Actavis Group PTC EHF - IS 0,53%

InterMetro Industries B.V. - NL 0,26%

Becton Dickinson Austria GmbH - AT 0,53%

JAC - GB 0,26%

Wolters Kluwer, Lexicomp - US 0,26%

Leventon, SAU - ES 0,26%

CODAN Triplus - SE 0,13%

Accord Healthcare LTD - GB 0,53%

Hospira - GB 0,79%

Synergy Medical Communications Ltd. Synergy House - GB 0,06%

Fagron Group - NL 0,26%

Bioquell UK Ltd - GB 0,26%

BITO-Lagertechnik Bittmann GmbH - DE 0,17%

AbbVie Biopharmaceuticals SARL - FR 1,06%

ROYAL PHARMACEUTICAL SOCIETY OF GREAT BRITAIN Pharmaceutical Press - GB 0,20%

Equashield Medical Ltd - IL 0,26%

EBEWE Pharma Ges.m.b.H. - AT 1,06%

Willach Pharmacy Solutions GmbH - DE 0,20%

Springer Verlag GmbH - DE 0,07%

Bayer Pharma AG - DE 0,34%

Truven Health Analytics - US 0,26%

IMPROMEDIFORM GmbH - DE 0,26%

Teva Pharmaceuticals - NL 0,53%

EuroBioConcept - FR 0,26%

Brocacef Supplies & Services - NL 0,10%

KIRO Robotics - ES 0,53%

Sol-Millennium Europe SP zo.o - PL 0,15%

EMA/800704/2012 Page 3/11

MYLAN EMEA SAS - FR 0,53%

Springer SBM BV - NL 0,07%

Aesynt - US 0,53%

Laboratoire AGUETTANT - FR 0,26%

NEWICO LTD - FI 0,53%

CareFusion Germany 326 GmbH - DE 0,79%

Cubist Pharmaceuticals GmbH - CH 0,34%

Mint Solutions Holland BV - NL 0,26%

GPI S.p.A. - IT 0,40%

Boehringer Ingelheim International GmbH - DE 1,06%

Biolog-ID - FR 0,10%

Pharmacolog AB - SE 0,05%

Hemedis GmbH - DE 0,10%

Nevo Medical - IL 0,26%

Betrace. Beldico IS - BE 0,32%

CIS Oncology Ltd - GB 0,26%

Hogg Robinson Switzerland Novartis Travel Center - CH 0,03%

SUB-TOTAL EXHIBITION 24,55%

SATELLITE Fresenius Kabi Deutschland Gmbh - DE 0,38%

Avantec Ltd - GB 0,38%

Accord Healthcare LTD - GB 0,38%

Synergy Medical Communications Ltd. Synergy House - GB 0,76%

Becton Dickinson UK Ltd - GB 0,32%

Teva Pharmaceuticals - NL 0,38%

Cubist Pharmaceuticals GmbH - CH 0,38%

Abbvie Inc. - US 0,38%

SUB-TOTAL SATELLITE 3,37%

ADVERTISING

INTERPLAN - DE 0,39%

Bayer Pharma AG - DE 4,77%

Baxter - CH 0,80%

EMA/800704/2012 Page 4/11

NOVARTIS FARMA S.P.A. - IT 3,18%

F. Hoffmann - La Roche AG - CH 4,77%

Amgen (Europe) GmbH - CH 3,18%

Pfizer - US 1,29%

Fresenius Kabi Deutschland Gmbh - DE 0,38%

Medi-Dose - US 0,06%

FIP International Pharmaceutical Federation - NL 0,02%

Actavis Group PTC EHF - IS 0,22%

InterMetro Industries B.V. - NL 0,05%

Accord Healthcare LTD - GB 0,31%

Synergy Medical Communications Ltd. Synergy House - GB 0,09%

Fresenius Kabi Deutschland GmbH - DE 0,03%

Equashield Medical Ltd - IL 0,03%

Teva Pharmaceuticals - NL 0,04%

Cubist Pharmaceuticals GmbH - CH 0,33%

Abbvie Inc. - US 0,05%

Health Robotics - IT 0,12%

20%

TOTAL EXHIBITION/SATELLITE/ADVERTISING 48%

REGISTRATION

Actavis, - SE 0,03%

HD Medi B.V. - NL 0,00%

Fresenius Kabi Deutschland Gmbh - DE 0,05%

Fresenius Kabi - BE 0,61%

Grifols International S.A. - ES 0,01%

Hameln Pharma plus GmbH - DE 0,01%

hameln pharmaceuticals ltd - GB 0,12%

IDIS - GB 0,05%

Medac GmbH - DE 0,63%

Omnicell - US 0,06%

F. Hoffmann - La Roche AG - CH 0,00%

ITAB Sintek International AB - SE 0,01%

EMA/800704/2012 Page 5/11

Pfizer bv - NL 0,27%

Sanofi-Aventis Deutschland GmbH - DE 0,06%

Qualiphar NV - BE 0,04%

Amgros I/S - DK 0,16%

Baxter Belgium sprl - BE 0,09%

B. Braun Medical AG - CH 0,04%

TEVA SANTE - FR 0,18%

Avantec Ltd, - GB 0,03%

Swisslog Healthcare Solutions - IT 0,10%

Bayer (Schweiz) AG - CH 0,02%

Roche Austria GmbH - AT 0,27%

Bayer B.V. - NL 0,09%

Mawdsleys - GB 0,07%

Baxter B.V. Business Unit Hospital (ref. GHOL6019) - NL 0,27%

Sandoz BV - NL 0,19%

JCE BIOTECHNOLOGY - FR 0,00%

Wockhardt UK Limited - GB 0,13%

Fresenius Kabi Nederland B.V. - NL 0,47%

Fagron nv - BE 0,00%

Biotest AG - DE 0,26%

BAYER AUSTRIA GESMBH - AT 0,03%

Fresenius Kabi France - FR 0,17%

Becton Dickinson Austria GmbH - AT 0,13%

B.Braun Medical EOOD, - BG 0,00%

JAC - GB 0,00%

Leventon, SAU - ES 0,01%

Takeda - NL 0,04%

CODAN Triplus - SE 0,01%

B. Braun Melsungen AG - DE 0,03%

Teva Pharma AG Switzerland - CH 0,38%

Accord Healthcare LTD - GB 0,00%

Amgen, - AE 0,08%

EMA/800704/2012 Page 6/11

MACO PRODUCTIONS - FR 0,18%

roche - BE 0,19%

B.Braun Medical Ltd - GB 0,19%

FRESENIUS KABI ITALIA SRL - IT 0,08%

Synergy Medical Communications Ltd. Synergy House - GB 0,04%

Fresenius Kabi s.r.o. - CZ 0,28%

Fagron Group - NL 0,01%

Takeda (Thailand) Limited - TH 0,05%

Pacific Pharma - LB 0,04%

BAYER S.A, - MA 0,00%

HOSPIRA BENELUX - BE 0,08%

Kent Pharmaceuticals Ltd - GB 0,04%

Quantum Pharmaceutical - GB 0,10%

Merck SARL - TN 0,36%

B Braun Medical A/S - DK 0,07%

Bioquell UK Ltd - GB 0,00%

VIOSER S.A. PARENTERAL SOLUTION INDUSTRY - GR -0,07%

TAKEDA PHARMA Ges.m.b.H. - AT 0,23%

Mylan EMEA S.A.S. - FR 0,02%

Abbott AG - CH 0,17%

AbbVie AG - CH 0,12%

Abbvie Ltd - GB 0,05%

Sandoz GmbH - AT 0,23%

B. Braun Medical s.r.o. - CZ 0,21%

AbbVie, - FR 0,03%

B.Braun Medical OÜ, - EE 0,02%

Icu medical europe - IT 0,01%

Celgene GmbH - DE 0,04%

Baxter Belgium SPRL - BE 0,31%

AbbVie sa/nv - BE 0,35%

EBEWE Pharma Ges.m.b.H. Nfg.KG - AT 0,05%

INPLANT, FRESENIUS - ES 0,02%

EMA/800704/2012 Page 7/11

Pfizer, - GB 0,02%

SANOFI - SA 0,25%

Truven Health Analytics - US 0,01%

Teva Pharmaceutical, - IE 0,00%

Novartis Pharmaceuticals UK Ltd Accounts Payable - GB 0,35%

Novartis Ireland Ltd - IE 0,25%

Lundbeck (Schweiz) AG - CH 0,05%

CareFusion - US 0,09%

Allergan Norden AB filial i Finland c/o Allergan Norden AB FI0969075-7 - SE 0,08%

sanofi-aventis Representative Office in Bosnia and Herzegovina - BA 0,14%

Sandoz Pharmaceuticals AG - CH 0,08%

Pfizer Congress Support - CH 0,31%

Fresenius Kabi (Schweiz) AG - CH 0,10%

Lipomed GmbH - AT 0,00%

Pfizer Deutschland, - DE 0,03%

Brocacef Supplies & Services BV - NL 0,00%

AbbVie B.V. - NL 0,25%

Fresenius Kabi Ab - FI 0,07%

Actavis EAD - BG 0,08%

Bayer Pharma - EG 0,18%

B. Braun Austria Ges.m.b.H., - AT 0,03%

Teva Pharmaceutical Industries Ltd., - IL 0,03%

Astellas Pharma Ltd - GB 0,21%

Sandoz - KW 0,08%

Biogen Idec (Czech Republic) s.r.o. - CZ 0,04%

Novartis - NL 0,04%

Laboratoire AGUETTANT - FR 0,01%

Cubist Pharmaceuticals GmbH - CH 0,08%

Medidose - US 0,00%

InterMetro Industries - US 0,00%

B. Braun Medical s.r.o. - SK 0,08%

Synthesis Group S.A. - GR 0,31%

EMA/800704/2012 Page 8/11

Fresenius-kabi (Thailand) Ltd. (Head Office) - TH 0,06%

TEVA GYÓGYSZERGYÁR ZÁRTKÖRUEN MUKÖDO RÉSZVÉNYTÁRSASÁG - HU 0,34%

medac GmbH (UK) - GB 0,00%

Abbvie - NO 0,04%

Bayer KAZ" LLP" - KZ 0,27%

INPLANT ABBVIE FARMACEUTICA, AMEXBARCELO - caballerorequejo.carmen - ES 0,02%

BAXTER HEALTHCARE LTD FINANCE DEPT - GB 0,16%

Biolog-ID - FR 0,00%

sanofi-aventis (Schweiz) ag Gian-Claudio Fontanella / Jeannette Seifert - CH 0,40%

BBraun Medical EOOD - BG 0,07%

Nevo Medical - IL 0,01%

AbbVie - IE 0,04%

HRG Switzerland LTD Novartis Travel Center - CH 0,11%

VIOSER S.A. 9klm TRIKALA-LARISA - GR 0,11%

Pharmamed (Hanan Akram Saab & Co) SAL - LB 0,07%

Baxter Healthcare Corp - US 0,05%

TEVA PHARMACEUTICALS EUROPE BV - NL 0,11%

MERCK SHARP & DOHME INTERNATIONAL SERVICES B.V. - NL 0,13%

Accord Health Care - SA 0,11%

Fresenius Kabi (Thailand) Ltd, (Head Office), Fresenius Kabi (Thailand) Ltd, (He - TH 0,02%

Helm AG - DE 0,03%

Hemedis GmbH - DE 0,00%

Bayer Middle East - AE 0,49%

Roche Pharma (Schweiz) AG - CH 0,14%

Health Robotics - IT 0,05%

Sol-Millennium Europe - PL 0,00%

FAGRON NEDERLAND B.V. - NL 0,08%

Mint Solutions HOLDING BV - NL 0,00%

Accord Healthcare GmbH - DE 0,24%

Pfizer Deutschland, - DE 0,03%

CIS ONCOLOGY LTD - GB 0,00%

Hospira GmbH, - DE 0,03%

EMA/800704/2012 Page 9/11

Hospira UK Ltd, - GB 0,03%

Novartis Poland Sp. z o.o. - PL 0,02%

Ing. Sumetzberger GMBH. - AT 0,03%

Becton Dickinson Management GmbH & Co KG - DE 0,28%

ROBOTIC S.L., KIRO - ES 0,03%

ROBOTICS S.L., KIRO - ES 0,03%

pfizer saudi arabia - SA 0,38%

Pfizer - BE 0,03%

CareFusion, - US 0,03%

pfizer, - MA 0,03%

Pfizer Pharma GmbH, - DE 0,01%

Pfizer Pharma GmbH, - DE 0,01%

Pfizer company, - SA 0,03%

Pfizer Ltd, - GB 0,03%

Pfizer, - GB 0,03%

Pfizer, - GB 0,03%

AbbVie, - IE 0,01%

Abbvie, - PT 0,01%

Novartis Pharma GmbH, - DE 0,02%

abbvie, - FR 0,01%

Fresenius Kabi, - GB 0,01%

Fresenius Kabi, - GB 0,01%

Baxter Healthcare Corporation, - US 0,02%

SUB-TOTAL REGISTRATION 16,23%

Subtotal: 64,29%

EMA/800704/2012 Page 10/11

Non-industry related income

Source of funding[1]

Percentage of

overall budget

Lietuvos Farmacijos Sajunga - LT 0,00%

APHL Clinique Ste. Thérèse / Service Pharmacie - LU 0,01%

Pharmacists` Society of Latvia - LV 0,01%

Malta Association of Hospital Pharmacists MAHP - MT 0,01%

Pharmaceutical Society of Iceland, Hospital Pharmacy section - IS 0,01%

Pharmaceutical societies of Bosnia & Herzegovina Section for Hospital and Clinic - BA 0,01%

Pharmaceutical Chamber of Macedonia - MK 0,01%

The National Association of Hospital Pharmacists from Romania ANFSR - RO 0,02%

Slovenian Pharmaceutical Society Section of Slovenian Hospital Pharmacy - SI 0,02%

Slovak Pharmaceutical Chamber Slovenská lekárnická komora - SK 0,02%

Hrvatsko Farmaceutsko Drustvo-Bolnicka Sekcija - HR 0,02%

Estonian Society of Hospital Pharmacists (ESHP) - EE 0,02%

Pharmaceutical Association of Serbia - RS 0,03%

Bulgarian Association of hospital pharmacists - BG 0,04%

Ceská farmaceutická spolecnost CLS JEP Sekce nemocnicních lékárníku - CZ 0,04%

Panhellenic Ass. of Hospital Pharmacists - GR 0,04%

AAHP - AT 0,04%

Polish Pharmaceutical Chamber Naczelna Izba Aptekarska - PL 0,04%

APFH Associação Portuguesa de Farmacêuticos Hospitalares - PT 0,05%

Magyar Korhazi Gyogyszereszetert - HU 0,05%

Swedish Academy of Pharmaceutical Sciences - SE 0,05%

Norwegian Ass. of Hospital Pharmacists Norsk Farmasøytisk Selskap - NO 0,05%

Hospital Pharmacists' Association of Irleland Portiuncula Hospital - IE 0,05%

GSASA Swiss Association of Public Health Administration and Hospital Pharmacists - CH 0,06%

TPA-Turkish Pharmacists Association - TR 0,07%

Finnish Pharmacists' Association - FI 0,08%

Pharmadanmark - DK 0,08%

EMA/800704/2012 Page 11/11

NVZA - Dutch Association of Hospital Pharmacists - NL 0,10%

Royal Pharmaceutical Society of Great Britain - GB 0,11%

Unite Health Office - GB 0,11%

SYNPREFH - FR 0,11%

Societa Italiana di Farmacia Ospedaliera-SIFO Tesoreria - IT 0,11%

ABPH - BVZA Cliniques Universitaires St. Luc-Service Pharmacie - BE 0,12%

ADKA - DE 0,14%

SEFH-Sociedad Espanola de Farmacia Hospitalaria - ES 0,17%

Subtotal membership fees: 1,88%

Subtotal congress registration fees individuals 32,04%

Subtotal interest and other income 1,79%

TOTAL: 100,00%